Microwave Chemical Co., Ltd.

The company is advancing applications of its microwave process into diverse fields such as food additives, pharmaceuticals, carbon materials, petrochemicals, electronic materials, and metal smelting. However, since these represent new technology areas, there is a risk that market penetration may not proceed as planned. Delays in technology adoption could directly affect business strategy and operating results. The company's policy is to address this through accumulating know-how via plant construction across multiple areas.

There is a risk that competitive advantage could decline due to the emergence of new entrants with R&D capabilities exceeding the company's own, or the development of alternative technologies that do not infringe on its patents. Furthermore, the emergence of alternative technologies to microwave technology itself could significantly change the industry environment. The company's policy is to address this by anticipating changes in customer needs and continuously monitoring competing technologies.

As an R&D-driven company, it is difficult to completely avoid the occurrence of intellectual property rights infringement issues with third parties, and if involved in legal disputes, resolution may require significant time and cost. Similarly, if a third party infringes on the company's technology, substantial costs may also be incurred, potentially having a material impact on business strategy and operating results. Currently, the company manages its intellectual property by classifying elemental technologies into categories of confidentiality, patenting, and public disclosure.

Total R&D expenses for the 18th fiscal year amounted to ¥437,647 thousand, with continued R&D on multiple next-generation pipelines focused on the priority areas of green chemistry, chemical recycling, and mining processes. If R&D is delayed relative to the initial plan or fails to achieve expected results, expenses may exceed the plan and adversely affect operating results and financial condition. The company's policy is to strive to record revenue through continued upfront investment and strengthened business development.

Since business revenue is centered on the receipt of upfront development payments associated with joint development contracts, there is a risk that business revenue and net income (loss) for the period may fluctuate unstably depending on the timing and amount of such recognition. In addition, there is seasonal variation in performance, with the completion timing of joint development tending to be concentrated in the second half of the fiscal year; in the 18th fiscal year, quarterly net sales were heavily skewed, with ¥69,158 thousand in the first quarter versus ¥931,133 thousand in the fourth quarter. Furthermore, if delays occur in customer acceptance inspection of deliverables, the timing of revenue recognition may shift, potentially affecting operating results.

Joint development contracts are concluded on a milestone-by-milestone basis, but continuation of development may become difficult due to development challenges or changes in the customer's management policy or budget cuts. In Phase 4 (Manufacturing Support), the commercialization stage, recurring revenue such as licensing income is anticipated; however, as of the filing date of this document, there is no track record of recurring revenue recognition, and there is a risk that commercialization of the pipeline may become difficult depending on the customer's business circumstances. If the pipeline does not progress as expected, this may directly affect operating results.

For projects at Phase 2 (Demonstration Development) and beyond, which have larger unit sales prices, sales from specific business partners currently account for a certain proportion of total sales. While this is expected to be resolved through stage advancement of Phase 1 (Lab Development) projects, if development progress becomes uneven, dependence on specific business partners may continue. If deterioration in the business environment of a specific business partner or changes in contract terms occur, this poses a risk of significantly impacting the company's revenue.

Representative Director and President CEO Iwao Yoshino plays a key role in management strategy and business development, while Representative Director and CSO Yasunori Tsukahara plays a key role in R&D in the field of microwave chemistry, resulting in a high degree of dependence on these directors. If, for any reason, these directors become unable to continue their involvement in the business, this could affect business strategy and operating results. The company aims to reduce this dependence through the recruitment of executive personnel and the establishment of various decision-making bodies to enable organizational decision-making and knowledge accumulation.

As of the end of the current fiscal year, the number of employees was 54 (including temporary staff), a small scale, and the internal management structure remains commensurately sized. If the company is unable to acquire necessary personnel, if personnel attrition occurs, or if replacement staff are unavailable, this could affect business strategy and operating results. The company's policy is to strengthen personnel as needed for operations and enhance its internal structure.

The company acquires and holds tangible and intangible fixed assets to build its Technology Platform for the microwave process. However, if profitability declines due to insufficient R&D outcomes, delays in business development, or significant changes in the business environment, recognition of impairment losses may become necessary. Recognition of impairment losses would directly affect the company's operating results. The company's policy is to thoroughly verify the necessity and profitability of asset acquisitions in advance.